Myoglobin immunoassay based on metal particle-enhanced fluorescence

Journal of Immunological Methods

Volumn 302, Issue 1-2, 2005, Pages 26-35

  Matveeva, Evgenia G ^a   Gryczynski, Zygmunt ^a   Lakowicz, Joseph R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac markers; Fluorescence immunoassay; Metal enhanced fluorescence; Myoglobin; Nano size metallic particles; Silver island films

Indexed keywords

ANTIBODY; METAL; MYOGLOBIN; SILVER;

ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); FLUORESCENCE; HUMAN; IMMUNOASSAY; INCUBATION TIME; NORMAL HUMAN; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; FLUORESCENT DYES; FLUOROIMMUNOASSAY; KINETICS; MYOGLOBIN; PROTEIN BINDING; RHODAMINES; STAINING AND LABELING;

EID: 23444434702     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2005.04.020     Document Type: Article

References (33)

1. F.S. Apple, R.H. Christenson, R. Valdes Jr., A.J. Andriak, A. Berg, S.H. Duh, Y.J. Feng, S.A. Jortani, N.A. Johnson, B. Koplen, K. Mascotti, and A.H. Wu Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction Clin. Chem. 45 2 1999 199
2. F.S. Apple, F.P. Anderson, P. Collinson, R.L. Jesse, M.C. Kontos, M.A. Levitt, E.A. Miller, and M.M. Murakami Clinical evaluation of the first medical whole blood, point-of-care testing device for detection of myocardial infarction Clin. Chem. 46 10 2000 1604
3. A.M. Castaldo, P. Ercolini, F. Forino, A. Basevi, L. Vrenna, P. Castaldo, V. D'Ambrosio, and A. Castaldo Plasma myoglobin in the early diagnosis of acute myocardial infarction Eur. J. Clin. Chem. Clin. Biochem. 32 5 1994 349
4. F. Di Serio, G. Antonelli, P. Trerotoli, M. Tampoia, A. Matarrese, and N. Pansini Appropriateness of point-of-care testing (POCT) in an emergency department Clin. Chim. Acta 333 2 2003 185
5. J.P. Egan Signal Detection Theory and ROC Analysis 1975 Academic Press New York 277
6. J. Ellenius, T. Groth, B. Lindahl, and L. Wallentin Early assessment of patients with suspected acute myocardial infarction by biochemical monitoring and neural network analysis Clin. Chem. 43 10 1997 1919
7. D.D. Evanoff Jr., and G. Chumanov Size-controlled synthesis of nanoparticles: 1. "Silver-Only" aqueous suspensions via hydrogen reduction J. Phys. Chem., B 108 37 2004 13948
8. F.M. Fesmire Improved identification of acute coronary syndromes with delta cardiac serum marker measurements during the emergency department evaluation of chest pain patients Cardiovasc. Toxicol. 1 2 2001 117
9. R.S. Galen The normal range: a concept in transition Arch. Pathol. Lab. Med. 101 11 1977 561
10. W.B. Gibler, A.L. Blomkalns, and S.P. Collins Evaluation of chest pain and heart failure in the emergency department: impact of multimarker strategies and B-type natriuretic peptide Rev. Cardiovasc. Med. 4 Suppl. 4 2003 S47
11. E. Hao, G.C. Schatz, and J.T. Hupp Synthesis and optical properties of anisotropic metal nanoparticles J. Fluoresc. 14 4 2004 331
12. A.R. Henderson An overview and ranking of biochemical markers of cardiac disease. Strengths and limitations Clin. Lab. Med. 17 4 1997 625
13. mass, myosin light chain 1, and myoglobin in the early in-hospital triage of "high risk" patients with chest pain Heart 82 5 1999 614
14. J.R. Lakowicz Radiative decay engineering: biophysical and biomedical applications Anal. Biochem. 298 1 2001 1
15. J.R. Lakowicz, Y. Shen, S. D'Auria, J. Malicka, Z. Gryczynski, and I. Gryczynski Radiative decay engineering: 2. Effects of silver island films on fluorescence intensity lifetimes and resonance energy transfer Anal. Biochem. 301 2 2002 261
16. J.R. Lakowicz, J. Malicka, S. D'Auria, and I. Gryczynski Release of the self-quenching of fluorescence near silver metallic surfaces Anal. Biochem. 320 1 2003 13
17. T. Laperche, P.G. Steg, M. Dehoux, J. Benessiano, G. Grollier, E. Aliot, J.-M. Mossard, P. Aubry, D. Coisne, M. Hanssen, and M.-Ch. Iliou A study of biochemical markers of reperfusion early after thrombolysis for acute myocardial infarction Circulation 92 1995 2079
18. J. Lim, R.C. Hawkins, K. Ng, S.P. Chan, A. Cheng, and K.S. Ng A preliminary study of the utility of combined cardiac markers in the evaluation of patients presenting early with suspected acute coronary syndrome Ann. Acad. Med. Singap. 31 6 2002 772
19. N. Lochner, C. Lobmaier, M. Wirth, A. Leitner, F. Pittner, and F. Gabor Silver nanoparticle enhanced immunoassays: one step real time kinetic assay for insulin in serum Eur. J. Pharm. Biopharm. 56 3 2003 469
20. B.R. Malasky, and J.S. Alpert Diagnosis of myocardial injury by biochemical markers: problems and promises Cardiol. Rev. 10 2002 306
21. T. Mathew, I. Menown, B. Smith, M. Smye, S. Nesbitt, I. Young, and A.A.J. Adgey Diagnosis and risk stratification of patients with anginal pain and non-diagnostic electrocardiograms Q. J. Med. 92 10 1999 565
22. E. Matveeva, Z. Gryczynski, J. Malicka, I. Gryczynski, and J.R. Lakowicz Metal-enhanced fluorescence immunoassays using total internal reflection and silver island-coated surfaces Anal. Biochem. 334 2 2004 303
23. J. McCord, R.M. Nowak, P.A. McCullough, C. Foreback, S. Borzak, G. Tokarski, M.C. Tomlanovich, G. Jacobsen, and D.W. Weaver Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I Circulation 104 13 2001 483
24. J. McCord, R.M. Nowak, M.P. Hudson, P.A. McCullough, M.C. Tomlanovich, G. Jacobsen, G. Tokarski, N. Khoury, and W.D. Weaver The prognostic significance of serial myoglobin, troponin I, and creatine kinase-MB measurements in patients evaluated in the emergency department for acute coronary syndrome Ann. Emerg. Med. 42 3 2003 343
25. C. Montague, and T. Kircher Myoglobin in the early evaluation of acute chest pain Am. J. Clin. Pathol. 104 4 1995 472
26. L.K. Newby, A.B. Storrow, W.B. Gibler, J.L. Garvey, J.F. Tucker, A.L. Kaplan, D.H. Schreiber, R.H. Tuttle, S.E. McNulty, and E.M. Ohman Bedside multimarker testing for risk stratification in chest pain units: the chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study Circulation 103 14 2001 1832
27. S.M. Ng, P. Krishnaswamy, R. Morissey, P. Clopton, R. Fitzgerald, and A.S. Maisel Ninety-minute accelerated critical pathway for chest pain evaluation Am. J. Cardiol. 88 6 2001 611
28. M. Panteghini The measurement of cardiac markers: where should we focus? Am. J. Clin. Pathol. 118 3 2002 354
29. A.B. Storrow, and W.B. Gibler The role of cardiac markers in the emergency department Clin. Chim. Acta 284 2 1999 187
30. R.J. de Winter, R.W. Koster, J.H. Schotveld, A. Sturk, J.P. Straalen, and G.T. Sanders Prognostic value of troponin T, myoglobin, and CK-MB mass in patients presenting with chest pain without acute myocardial infarction Heart 75 3 1996 235
31. J. Woo, F.L. Lacbawan, R. Sunheimer, D. LeFever, and J.B. McCabe Is myoglobin useful in the diagnosis of acute myocardial infarction in the emergency department setting? Am. J. Clin. Pathol. 103 6 1995 725
32. A.H. Wu Biochemical markers of cardiac damage: from traditional enzymes to cardiac-specific proteins. IFCC subcommittee on standardization of cardiac markers (S-SCM) Scand. J. Clin. Lab. Invest., Suppl. 230 1999 74
33. M. Zaninotto, S. Altinier, M. Lachin, L. Celegon, and M. Plebani Strategies for the early diagnosis of acute myocardial infarction using biochemical markers Am. J. Clin. Pathol. 111 3 1999 399